Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 20, 2000

View Archived Issues

Magainin presents new anticancer magainin peptide at H&Q

Esperion Therapeutics acquires novel peptides

Phoenix and CuraGen enter transgenic research agreement

QS-21 license granted to Elan

Ampakines increase neurotrophin expression in rats and mice

Immune Response receives USD 5 million payment from Agouron

North American Vaccine to seek NeisVac-C approval in U.K. shortly

Gliatech and Abgenix enter XenoMouse technology collaboration

Oxford BioMedica's LentiVector has potential application in cancer

SBIR grant awarded to Vion to advance preclinical development of TAPET vectors

Lipid-lowering compounds designed at HMR (Aventis)

Novel rotamase inhibitors with neurotrophic activity in development at BMS

Antiobesity agents from Novartis target the NPY Y5 receptor

Sepracor initiates large-scale study of (+)-zopiclone

Potassium channel inhibitors for arrhythmias emerge from ICAgen/Lilly collaboration

Searle designs double prodrugs of gpIIb/IIIa antagonists

Hyperforin acetate: stable hyperforin derivative with superior pharmacological activity

Beta-sheet breaker peptides: new hope for rare but devastating neurodegenerative diseases

Vasogen to begin clinical trial with VAS-991 for treatment of congestive heart failure

Xyrem reduces narcolepsy-associated cataplexy and EDS in the clinic

Clinical trial commences with Cell Therapeutics' novel paclitaxel

Joint venture formed by Ribozyme and Elan to develop anticancer ribozyme product

Myriad Genetics patent covers p19 therapeutic and diagnostic development

Novel, nonviral gene delivery method in development at Genteric; U.S. patent issued

CardioRex phase II trials scheduled to begin this quarter

Major European launch announced for Synagis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...